Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × pazopanib × Clear all

Phase

Status

Completed 18 Terminated 6 Withdrawn 3 Active not recruiting 3 Recruiting 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 5 Relapsed Pediatric Solid Tumor 2 Ovarian Neoplasms 2 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Breast Neoplasms 1

Interventions

Doxorubicin 14 Radiotherapy 9 Ifosfamide 9 Cyclophosphamide 8 apatinib 7 anlotinib 7 Vincristine 5 Dactinomycin 5 toripalimab 3 camrelizumab 3 Trabectedin 3 Etoposide 3 Docetaxel 3 brostallicin 2 Topotecan 2 Temozolomide 2 Sorafenib 2 Radiation Dose Hypofractionation 2 Oncolytic Virotherapy 2 Nivolumab 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ipilimumab 2 Gene Expression Profiling 2 Gemcitabine 2 Drug Therapy 2 Busulfan 2 Amplified Fragment Length Polymorphism Analysis 2 trofosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04741438 2023-08-30

RAR-Immune

Centre Leon Berard

Phase 3 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡